InvestorsHub Logo
Followers 121
Posts 14167
Boards Moderated 0
Alias Born 06/02/2004

Re: None

Thursday, 03/05/2015 3:02:21 PM

Thursday, March 05, 2015 3:02:21 PM

Post# of 91007
Why all the silence?

It benefits nobody, so why? Prevent conversions? Maybe, but cd holders must already be clued in. Could it be competitive purposes? I go back to this whole Andrews-Inventiv-Hill combination.

Andrews/Inventiv gets hired last spring
Inventiv has major private equity backers
Hill is clearly Inventiv's point man in those PRs
Late summer they file pre-IND
Hill becomes director of SVFC
Hill leaves Inventiv Nov-14
Hill gets equity into SVFC

OA of the knee is one thing, but what about elbow, hip, shoulder, wrist? This combination could create a juggernaut in arthritis and pain therapy using stem cells from Intellicell's superior extraction and clinical and treatment experiences of Andrews and led by the likes of Hill. OA and pain is their stated focus. The continued silence suggests heavily this combination is still on point. Money behind all of this calls the shots and pulls the levers. Imagine the institutional interest a company described above could gather. What is the therapy market for OA and pain worth?? Ans. Billions

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.